NewsSource: EClinCloud

Product Introduction | RM · Resource Management

2 min readEClinCloud Editorial Team
Article illustration

Source: EClinCloud. Author: EClinCloud.

Article illustration



● Are employee work assignments reasonable? Is the work process monitorable, traceable, and predictable?


● Are workforce recruitment, deployment, development, retention, and downsizing handled appropriately? Do current human resources meet the needs of the company's business scale?


● Is contract breakdown reasonable? How can profit from a contract be maximized?


● How can contract progress be tracked in real time and project risks controlled so that project payments are collected as quickly as possible?


● How can you evaluate whether a project is ultimately profitable?



What is EClinCloud RM?

EClinCloud's Resource Management (RM) system is a contract and workforce management solution designed specifically for pharmaceutical companies and CROs across the entire medical research lifecycle. It not only supports decomposing tasks by contract and estimating work hours based on the contract schedule—along with end-to-end tracking and management across timesheet entry, actual progress confirmation, and report analysis—but also enables targeted cost and expense control as well as scientific and effective project process oversight to meet clinical trial requirements.


At the same time, by quantifying human resource data across different roles, it turns human resources into a key source of competitive advantage and core competitiveness for the enterprise, achieving modern lean human resource management.


Article illustration


What are the functional features of EClinCloud RM?

Article illustration



What services does EClinCloud RM provide?

End-to-end service from professional project managers with 5+ years of experience

24/7 customer service hotline

End-to-end clinical trial management on an integrated platform

Regular communication and follow-up meetings

Regular product iterations

Disaster response, database backup, and long-term data archiving

Data migration supporting integration of multi-party data and documents

Comprehensive quality control to support regulatory inspections



Why choose EClinCloud RM?

Article illustration


| About EClinCloud |

EClinCloud is a healthcare and life sciences technology company rooted in China and serving the world. Guided by the mission of "bringing effective treatments to patients through technological innovation" and driven by science and medicine, it combines digital technology with life data to build an end-to-end digital clinical trial cloud platform and provide technical solutions for clinical endpoint assessment, helping domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the market launch of drugs and devices, and benefit countless patients.



Article illustration

Read the original WeChat article

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.